More info ›
Acadia Pharma’s (ACAD) Nuplazid Approved by FDA For Hallucinations and Delusions Associated with Parkinson’s
Why Digital Health Growth Will Come From Clinically-Tested, Consumer-Facing, Interoperable Products
CMS finalizes Medicaid managed care overhaul: 5 things to know
340B Coalition Winter Conference
FAH (Federation of American Hospitals)
MHA Business Summit
The US Oncology Network Hosts Second Annual Boot Camp Focusing on New Value-Based Care and Payment Models
McKesson Specialty Health Expands Provider Offerings with Acquisition of intraFUSION
McKesson Corporation to Webcast Investor Day
Please complete the information below and a McKesson representative will be in touch with you shortly.
Thank you for contacting us. We look forward to talking with you. We will be in touch with you within 24-48 hours.